On episode #38 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 9/14 – 9/27/23.
Become a patron of Puscast!
Links for this episode
- Features of Long COVID identified through immune profiling (Nature)
- Severity of influenza-associated hospitalizations by influenza type (The Lancet)
- Cefazolin for the treatment of CNS infections (CID)
- Rifampin based therapy for patients with Staphylococcus aureus native vertebral Osteomyelitis (CID)
- State of the management of infections caused by multidrug-resistant organisms (CID)
- Are contact precautions “essential” for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus? (CID)
- Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (ICHE)
- Update on outbreak of fungal meningitis among US residents who received epidural anesthesia at two clinics in Mexico (CID)
- Paratracheal abscess by plant fungus Chondrostereum purpureum (MMCR)
- Canadian Blood Services traceback investigation of a suspected case of transfusion-transmitted malaria (Transfusion)
- Strongyloides infection screening in transplant candidates (TID)
- The world of microbial odors (JID)
Music is by Ronald Jenkees